Growth Metrics

Exact Sciences (EXAS) Amortization of Deferred Charges (2016 - 2020)

Exact Sciences (EXAS) has disclosed Amortization of Deferred Charges for 11 consecutive years, with -$34.2 million as the latest value for Q4 2020.

  • On a quarterly basis, Amortization of Deferred Charges fell 22.69% to -$34.2 million in Q4 2020 year-over-year; TTM through Dec 2020 was $1.5 million, a 46.52% decrease, with the full-year FY2022 number at $5.7 million, down 14.3% from a year prior.
  • Amortization of Deferred Charges was -$34.2 million for Q4 2020 at Exact Sciences, down from $1.1 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $29.4 million in Q3 2019 to a low of -$34.2 million in Q4 2020.
  • A 5-year average of $338100.0 and a median of $14000.0 in 2016 define the central range for Amortization of Deferred Charges.
  • Biggest YoY gain for Amortization of Deferred Charges was 85341.67% in 2018; the steepest drop was 75592.86% in 2018.
  • Exact Sciences' Amortization of Deferred Charges stood at $12000.0 in 2016, then plummeted by 433.33% to -$40000.0 in 2017, then soared by 5567.5% to $2.2 million in 2018, then crashed by 1375.13% to -$27.9 million in 2019, then fell by 22.69% to -$34.2 million in 2020.
  • Per Business Quant, the three most recent readings for EXAS's Amortization of Deferred Charges are -$34.2 million (Q4 2020), $1.1 million (Q3 2020), and $20.1 million (Q2 2020).